M4MM

Silo Pharma Initiates Safety Study for PTSD Drug SPC-15

LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, has commenced a 7-day safety and toxicology study for its lead candidate, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The study is being conducted ...

Silo Pharma Initiates Safety Study for PTSD Drug SPC-15

LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, has commenced a 7-day safety and toxicology study for its lead candidate, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The study is being conducted ...

Red Light Holland Reports Q1 2025

LOS ANGELES- Red Light Holland, an Ontario-based corporation specializing in the production, growth, and sale of functional mushrooms, mushroom home grow kits, and psilocybin truffles, has announced its financial and operational results for the three ...

Curaleaf Reports Revenue Growth in Q2 2024

LOS ANGELES- Curaleaf Holdings, Inc. reported a net loss of $49.8 million for Q2 2024, bringing its year-to-date losses to over $100 million. Despite these losses, the company achieved a 2% increase in revenue, reaching ...

The Cannabist Reports Mixed Q2 2024 Results

LOS ANGELES- The Cannabist Company Holdings Inc. (OTC: CBSTF), formerly known as Columbia Care, delivered a mixed performance for Q2 2024. The company reported $125 million in revenue, a 2% sequential increase but a drop ...

Verano Holdings Reports Mixed Q2 2024 Results

LOS ANGELES- Verano Holdings Corp. reported mixed financial results for Q2 2024, with revenue reaching $222 million, reflecting a 0.5% increase from the previous quarter but a 5% decline year-over-year. The revenue aligned with the ...

Subscribe To Our Newsletter